Salvia miltiorrhiza bunge extracts: a promising source for anti-atopic dermatitis activity.
Salvia miltiorrhiza Bunge
Anti-atopic dermatitis
Anti-inflammatory
Antioxidant
Bio-guided fractionation
HPLC-DAD
Phenolics
Tanshinones
UPLC-TQ-MS/MS
Journal
BMC complementary medicine and therapies
ISSN: 2662-7671
Titre abrégé: BMC Complement Med Ther
Pays: England
ID NLM: 101761232
Informations de publication
Date de publication:
06 Jun 2024
06 Jun 2024
Historique:
received:
11
01
2024
accepted:
28
05
2024
medline:
7
6
2024
pubmed:
7
6
2024
entrez:
6
6
2024
Statut:
epublish
Résumé
Atopic dermatitis (AD) is a chronic inflammatory condition characterized by the accumulation of reactive oxygen species and the expression of inflammatory factors. Regarding its anti-atopic activity, numerous traditional medicinal materials and secondary metabolic products play pivotal roles in modulating the associated mechanisms. This study aimed to utilize Salvia miltiorrhiza Bunge (SMB) as an anti-AD source. In-vitro activity assessments and qualitative and quantitative analyses using UPLC-TQ-MS/MS and HPLC-DAD were conducted in two cultivars ('Dasan' and 'Kosan'). Statistical analysis indicated that the profiles of their secondary metabolites contribute significantly to their pharmacological properties. Consequently, bio-guided fractionation was undertaken to figure out the distinct roles of the secondary metabolites present in SMB. Comparative study of two cultivars indicated that 'Dasan', having higher salvianolic acid A and B, exhibited stronger antioxidant and anti-inflammatory activities. Meanwhile, 'Kosan', containing higher tanshinones, showed higher alleviating activities on anti-AD related genes in mRNA levels. Additionally, performed bio-guided fractionation re-confirmed that the hydrophilic compounds of SMB can prevent AD by inhibiting accumulation of ROS and suppressing inflammatory factors and the lipophilic components can directly inhibit AD. SMB was revealed as a good source for anti-AD activity. Several bioactive compounds were identified from the UPLC-TQ-MS/MS and different compounds content was linked to biological activities. Characterization of these compounds may be helpful to understand differential role of secondary metabolites from SMB on alleviation of AD.
Sections du résumé
BACKGROUND
BACKGROUND
Atopic dermatitis (AD) is a chronic inflammatory condition characterized by the accumulation of reactive oxygen species and the expression of inflammatory factors. Regarding its anti-atopic activity, numerous traditional medicinal materials and secondary metabolic products play pivotal roles in modulating the associated mechanisms.
METHODS
METHODS
This study aimed to utilize Salvia miltiorrhiza Bunge (SMB) as an anti-AD source. In-vitro activity assessments and qualitative and quantitative analyses using UPLC-TQ-MS/MS and HPLC-DAD were conducted in two cultivars ('Dasan' and 'Kosan'). Statistical analysis indicated that the profiles of their secondary metabolites contribute significantly to their pharmacological properties. Consequently, bio-guided fractionation was undertaken to figure out the distinct roles of the secondary metabolites present in SMB.
RESULTS
RESULTS
Comparative study of two cultivars indicated that 'Dasan', having higher salvianolic acid A and B, exhibited stronger antioxidant and anti-inflammatory activities. Meanwhile, 'Kosan', containing higher tanshinones, showed higher alleviating activities on anti-AD related genes in mRNA levels. Additionally, performed bio-guided fractionation re-confirmed that the hydrophilic compounds of SMB can prevent AD by inhibiting accumulation of ROS and suppressing inflammatory factors and the lipophilic components can directly inhibit AD.
CONCLUSIONS
CONCLUSIONS
SMB was revealed as a good source for anti-AD activity. Several bioactive compounds were identified from the UPLC-TQ-MS/MS and different compounds content was linked to biological activities. Characterization of these compounds may be helpful to understand differential role of secondary metabolites from SMB on alleviation of AD.
Identifiants
pubmed: 38844985
doi: 10.1186/s12906-024-04524-z
pii: 10.1186/s12906-024-04524-z
doi:
Substances chimiques
Plant Extracts
0
Anti-Inflammatory Agents
0
Antioxidants
0
Reactive Oxygen Species
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
217Subventions
Organisme : Korea Institute of Science and Technology, South Korea
ID : 2Z06831
Organisme : National Research Council of Science and Technology
ID : CPS22041-110
Informations de copyright
© 2024. The Author(s).
Références
Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Investig. 2004;113(5):651–7.
pubmed: 14991059
pmcid: 351324
doi: 10.1172/JCI21060
Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol. 2003;112(6):S118–27.
pubmed: 14657842
doi: 10.1016/j.jaci.2003.09.033
Novak N, Bieber T. Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol. 2003;112(2):252–62.
pubmed: 12897728
doi: 10.1067/mai.2003.1595
Dharmage SC, Lowe A, Matheson MC, Burgess J, Allen K, Abramson MJ. Atopic dermatitis and the atopic march revisited. Allergy. 2014;69(1):17–27.
pubmed: 24117677
doi: 10.1111/all.12268
Smith SD, Hong E, Fearns S, Blaszczynski A, Fischer G. Corticosteroid phobia and other confounders in the treatment of childhood atopic dermatitis explored using parent focus groups. Australas J Dermatol. 2010;51(3):168–74.
pubmed: 20695854
doi: 10.1111/j.1440-0960.2010.00636.x
Lee D-h, Park J-k, Choi J, Jang H, Seol J-w. Anti-inflammatory effects of natural flavonoid diosmetin in IL-4 and LPS-induced macrophage activation and atopic dermatitis model. Int Immunopharmacol. 2020;89:107046.
pubmed: 33045572
pmcid: 7545212
doi: 10.1016/j.intimp.2020.107046
Lee H-S, Kim E-N, Jeong G-S. Oral administration of liquiritigenin confers protection from atopic dermatitis through the inhibition of T cell activation. Biomolecules. 2020;10(5):786.
pubmed: 32438694
pmcid: 7277419
doi: 10.3390/biom10050786
Wu S, Pang Y, He Y, Zhang X, Peng L, Guo J, Zeng J. A comprehensive review of natural products against atopic dermatitis: flavonoids, alkaloids, terpenes, glycosides and other compounds. Biomed Pharmacother. 2021;140:111741.
pubmed: 34087696
doi: 10.1016/j.biopha.2021.111741
Boyce ST, Supp AP, Swope VB, Warden GD. Vitamin C regulates keratinocyte viability, epidermal barrier, and basement membrane in vitro, and reduces wound contraction after grafting of cultured skin substitutes. J Invest Dermatology. 2002;118(4):565–72.
doi: 10.1046/j.1523-1747.2002.01717.x
Kim H-S, Ahn J-J, Choi T-H, Hwang T-Y. Screening of DPPH radical scavenging and antimicrobial activity of extracts from local some native plants. Korean J Food Preservation. 2014;21(4):593–9.
doi: 10.11002/kjfp.2014.21.4.593
Cuellar M, Giner R, Recio M, Just M, Máñez S, Cerda S, Ríos J. Screening of antiinflammatory medicinal plants used in traditional medicine against skin diseases. Phytotherapy Research: Int J Devoted Pharmacol Toxicol Evaluation Nat Prod Derivatives. 1998;12(1):18–23.
doi: 10.1002/(SICI)1099-1573(19980201)12:1<18::AID-PTR180>3.0.CO;2-3
Jiang Z, Gao W, Huang L. Tanshinones, critical pharmacological components in Salvia miltiorrhiza. Front Pharmacol. 2019;10:202.
pubmed: 30923500
pmcid: 6426754
doi: 10.3389/fphar.2019.00202
Pan X, Niu G, Liu H. Microwave-assisted extraction of tanshinones from Salvia miltiorrhiza bunge with analysis by high-performance liquid chromatography. J Chromatogr A. 2001;922(1–2):371–5.
pubmed: 11486886
doi: 10.1016/S0021-9673(01)00949-9
Matkowski A, Zielińska S, Oszmiański J, Lamer-Zarawska E. Antioxidant activity of extracts from leaves and roots of Salvia miltiorrhiza Bunge, S. Przewalskii Maxim., and S. Verticillata L. Bioresour Technol. 2008;99(16):7892–6.
pubmed: 18396038
doi: 10.1016/j.biortech.2008.02.013
Gordon M, Weng X. Antioxidant properties of extracts from tanshen (Salvia miltiorrhiza Bunge). Food Chem. 1992;44(2):119–22.
doi: 10.1016/0308-8146(92)90322-S
Jia Q, Zhu R, Tian Y, Chen B, Li R, Li L, Wang L, Che Y, Zhao D, Mo F. Salvia miltiorrhiza in diabetes: a review of its pharmacology, phytochemistry, and safety. Phytomedicine. 2019;58:152871.
pubmed: 30851580
doi: 10.1016/j.phymed.2019.152871
Fan G, Jiang X, Wu X, Fordjour PA, Miao L, Zhang H, Zhu Y, Gao X. Anti-inflammatory activity of Tanshinone IIA in LPS-Stimulated RAW264.7 macrophages via miRNAs and TLR4-NF-kappaB pathway. Inflammation. 2016;39(1):375–84.
pubmed: 26639663
doi: 10.1007/s10753-015-0259-1
Zhang Y, Won S-H, Jiang C, Lee H-J, Jeong S-J, Lee E-O, Zhang J, Ye M, Kim S-H, Lü J. Tanshinones from Chinese medicinal herb Danshen (Salvia Miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling. Pharm Res. 2012;29(6):1595–608.
pubmed: 22281759
doi: 10.1007/s11095-012-0670-3
Chen X, Guo J, Bao J, Lu J, Wang Y. The anticancer properties of Salvia miltiorrhiza Bunge (Danshen): a systematic review. Med Res Rev. 2014;34(4):768–94.
pubmed: 24123144
doi: 10.1002/med.21304
Kum KY, Kirchhof R, Luick R, Heinrich M. Danshen (Salvia miltiorrhiza) on the Global Market: what are the implications for products’ quality? Front Pharmacol 2021, 12.
Jung I, Kim H, Moon S, Lee H, Kim B. Overview of Salvia miltiorrhiza as a potential therapeutic agent for various diseases: an update on efficacy and mechanisms of action. Antioxidants. 2020;9(9):857.
pubmed: 32933217
pmcid: 7555792
doi: 10.3390/antiox9090857
Gao H, Huang L, Ding F, Yang K, Feng Y, Tang H, Xu Q-m, Feng J, Yang S. Simultaneous purification of dihydrotanshinone, tanshinone I, cryptotanshinone, and tanshinone IIA from Salvia miltiorrhiza and their anti-inflammatory activities investigation. Sci Rep. 2018;8(1):1–13.
Liu H, Wang X, Wang D, Zou Z, Liang Z. Effect of drought stress on growth and accumulation of active constituents in Salvia miltiorrhiza Bunge. Ind Crops Prod. 2011;33(1):84–8.
doi: 10.1016/j.indcrop.2010.09.006
Chen Y-H, Du G-H, Zhang J-T. Salvianolic acid B protects brain against injuries caused by ischemia-reperfusion in rats. Acta Pharmacol Sin. 2000;21(5):463–6.
pubmed: 11324448
Du G-H, Qiu Y, Zhang J-T. Salvianolic acid B protects the memory functions against transient cerebral ischemia in mice. J Asian Nat Prod Res. 2000;2(2):145–52.
pubmed: 11252679
doi: 10.1080/10286020008039903
Park MJ, Ryu DH, Cho JY, Ha IJ, Moon JS, Kang Y-H. Comparison of the antioxidant properties and flavonols in various parts of Korean red onions by multivariate data analysis. Hortic Environ Biotechnol. 2018;59(6):919–27.
doi: 10.1007/s13580-018-0091-2
Park MJ, Ryu DH, Cho JY, Lee DG, Lee JN, Kang Y-H. Potential for antioxidant and antihyperglycemic activities of four everbearing strawberry cultivars. Hortic Environ Biotechnol. 2020;61(3):615–23.
doi: 10.1007/s13580-020-00240-y
Ryu DH, Cho JY, Sadiq NB, Kim JC, Lee B, Hamayun M, Lee TS, Kim HS, Park SH, Nho CW, et al. Optimization of antioxidant, anti-diabetic, and anti-inflammatory activities and ganoderic acid content of differentially dried Ganoderma lucidum using response surface methodology. Food Chem. 2021;335:127645.
pubmed: 32738537
doi: 10.1016/j.foodchem.2020.127645
Yu H-S, Kim W-J, Bae W-Y, Lee N-K, Paik H-D. Inula britannica inhibits adipogenesis of 3T3-L1 preadipocytes via modulation of mitotic clonal expansion involving ERK 1/2 and akt signaling pathways. Nutrients. 2020;12(10):3037.
pubmed: 33023055
pmcid: 7599673
doi: 10.3390/nu12103037
Yu H-S, Lee N-K, Choi A-J, Choe J-S, Bae CH, Paik H-D. Anti-inflammatory potential of probiotic strain Weissella cibaria JW15 isolated from kimchi through regulation of NF-κB and MAPKs pathways in LPS-induced RAW 264.7 cells. 2019.
Chelombitko M. Role of reactive oxygen species in inflammation: a minireview. Mosc Univ Biol Sci Bull. 2018;73:199–202.
doi: 10.3103/S009639251804003X
Ranneh Y, Ali F, Akim AM, Hamid HA, Khazaai H, Fadel A. Crosstalk between reactive oxygen species and pro-inflammatory markers in developing various chronic diseases: a review. Appl Biol Chem. 2017;60(3):327–38.
doi: 10.1007/s13765-017-0285-9
Tsiogka A, Kyriazopoulou M, Kontochristopoulos G, Nicolaidou E, Stratigos A, Rigopoulos D, Gregoriou S. The JAK/STAT pathway and its selective inhibition in the treatment of atopic dermatitis: a systematic review. J Clin Med. 2022;11(15):4431.
pubmed: 35956047
pmcid: 9369061
doi: 10.3390/jcm11154431
Bao L, Zhang H, Chan LS. The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis. Jak-Stat. 2013;2(3):e24137.
pubmed: 24069552
pmcid: 3772104
doi: 10.4161/jkst.24137
Liang S, Wang Z, Yuan J, Zhang J, Dai X, Qin F, Zhang J, Sun Y. Rapid Identification of Tanshinone IIA Metabolites in an Amyloid-β1–42 Induced Alzherimer’s Disease Rat Model using UHPLC-Q-Exactive Qrbitrap Mass Spectrometry. Molecules. 2019;24(14):2584.
pubmed: 31315255
pmcid: 6680413
doi: 10.3390/molecules24142584
Zhang Y, Li X, Wang Z. Antioxidant activities of leaf extract of Salvia miltiorrhiza Bunge and related phenolic constituents. Food Chem Toxicol. 2010;48(10):2656–62.
pubmed: 20600528
doi: 10.1016/j.fct.2010.06.036
Harris IS, DeNicola GM. The complex interplay between antioxidants and ROS in cancer. Trends Cell Biol. 2020;30(6):440–51.
pubmed: 32303435
doi: 10.1016/j.tcb.2020.03.002
Potts JM, Sharma R, Pasqualotto F, Nelson D, Hall G, Agarwal A. Association of Ureaplasma urealyticum with abnormal reactive oxygen species levels and absence of leukocytospermia. J Urol. 2000;163(6):1775–8.
pubmed: 10799180
doi: 10.1016/S0022-5347(05)67540-4
Trachootham D, Lu W, Ogasawara MA, Valle NR-D, Huang P. Redox regulation of cell survival. Antioxid Redox Signal. 2008;10(8):1343–74.
pubmed: 18522489
pmcid: 2932530
doi: 10.1089/ars.2007.1957
Ansari MY, Ahmad N, Haqqi TM. Oxidative stress and inflammation in osteoarthritis pathogenesis: role of polyphenols. Biomed Pharmacother. 2020;129:110452.
pubmed: 32768946
pmcid: 8404686
doi: 10.1016/j.biopha.2020.110452
Lismont C, Nordgren M, Van Veldhoven PP, Fransen M. Redox interplay between mitochondria and peroxisomes. Front cell Dev Biology. 2015;3:35.
doi: 10.3389/fcell.2015.00035
Agarwal A, Sekhon LH. The role of antioxidant therapy in the treatment of male infertility. Hum Fertility. 2010;13(4):217–25.
doi: 10.3109/14647273.2010.532279
Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44–84.
pubmed: 16978905
doi: 10.1016/j.biocel.2006.07.001
Dutta S, Sengupta P, Slama P, Roychoudhury S. Oxidative stress, testicular inflammatory pathways, and male reproduction. Int J Mol Sci. 2021;22(18):10043.
pubmed: 34576205
pmcid: 8471715
doi: 10.3390/ijms221810043
Tur J, Vico T, Lloberas J, Zorzano A, Celada A. Chapter One - Macrophages and Mitochondria: A Critical Interplay Between Metabolism, Signaling, and the Functional Activity. In: Advances in Immunology. Volume 133, edn. Edited by Alt FW: Academic Press; 2017: 1–36.
Ahmad N, Ansari MY, Haqqi TM. Role of iNOS in osteoarthritis: pathological and therapeutic aspects. J Cell Physiol. 2020;235(10):6366–76.
pubmed: 32017079
pmcid: 8404685
doi: 10.1002/jcp.29607
Tak PP, Firestein GS. NF-κB: a key role in inflammatory diseases. J Clin Investig. 2001;107(1):7–11.
pubmed: 11134171
pmcid: 198552
doi: 10.1172/JCI11830
Kumar S, Boehm J, Lee JC. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discovery. 2003;2(9):717–26.
pubmed: 12951578
doi: 10.1038/nrd1177
Lee H, Lee DH, Oh J-H, Chung JH. Skullcapflavone II suppresses TNF-α/IFN-γ-Induced TARC, MDC, and CTSS Production in HaCaT cells. Int J Mol Sci. 2021;22(12):6428.
pubmed: 34208434
pmcid: 8233710
doi: 10.3390/ijms22126428
Liu T, Zhang L, Joo D, Sun S-C. NF-κB signaling in inflammation. Signal Transduct Target Therapy. 2017;2(1):1–9.
Leung DY. New insights into atopic dermatitis: role of skin barrier and immune dysregulation. Allergology Int. 2013;62(2):151–61.
doi: 10.2332/allergolint.13-RAI-0564
Kim H, Cho S, Chung B, Ahn H, Park C, Lee C. Expression of CCL1 and CCL18 in atopic dermatitis and psoriasis. Clin Exp Dermatol. 2012;37(5):521–6.
pubmed: 22680616
doi: 10.1111/j.1365-2230.2011.04295.x
Meng J, Li Y, Fischer MJ, Steinhoff M, Chen W, Wang J. Th2 modulation of transient receptor potential channels: an unmet therapeutic intervention for atopic dermatitis. Front Immunol. 2021;12:2590.
doi: 10.3389/fimmu.2021.696784
Su C, Yang T, Wu Z, Zhong J, Huang Y, Huang T, Zheng E. Differentiation of T-helper cells in distinct phases of atopic dermatitis involves Th1/Th2 and Th17/Treg. Eur J Inflamm. 2017;15(1):46–52.
doi: 10.1177/1721727X17703271
Leung T, Wong C, Lam C, Li A, Ip W, Wong G, Fok T. Plasma TARC concentration may be a useful marker for asthmatic exacerbation in children. Eur Respir J. 2003;21(4):616–20.
pubmed: 12762345
doi: 10.1183/09031936.03.00083303
Gyeoung-Jin K, Hye-Ja L, Weon-Jong Y, Eun-Jin Y, Sun-Son P, Hee-Kyoung K, Myung-Hwan P. Prunus yedoensis inhibits the inflammatory chemokines, MDC and TARC, by regulating the STAT1-signaling pathway in IFN-γ-stimulated HaCaT human keratinocytes. Biomolecules Ther. 2008;16(4):394–402.
doi: 10.4062/biomolther.2008.16.4.394
Chang K-T, Lin HY-H, Kuo C-H, Hung C-H. Tacrolimus suppresses atopic dermatitis-associated cytokines and chemokines in monocytes. J Microbiol Immunol Infect. 2016;49(3):409–16.
pubmed: 25315214
doi: 10.1016/j.jmii.2014.07.006
Sebastiani S, Albanesi C, De Pità O, Puddu P, Cavani A, Girolomoni G. The role of chemokines in allergic contact dermatitis. Arch Dermatol Res. 2002;293:552–9.
pubmed: 11876523
doi: 10.1007/s00403-001-0276-9
Ichiishi E, Li X-K, Iorio EL. Oxidative stress and diseases: clinical trials and approaches. In., vol. 2016: Hindawi; 2016.